Agilent Technologies, Inc. (NYSE:A – Get Rating) – Research analysts at SVB Leerink lifted their FY2023 EPS estimates for shares of Agilent Technologies in a note issued to investors on Friday, January 6th. SVB Leerink analyst P. Souda now anticipates that the medical research company will earn $5.67 per share for the year, up from their previous forecast of $5.63. SVB Leerink has an “Outperform” rating and a $170.00 price objective on the stock. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.64 per share. SVB Leerink also issued estimates for Agilent Technologies’ Q4 2023 earnings at $1.64 EPS, FY2024 earnings at $6.22 EPS and FY2025 earnings at $7.08 EPS.
Several other research analysts have also issued reports on A. Citigroup increased their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 22nd. Cowen raised their price objective on shares of Agilent Technologies from $160.00 to $168.00 in a research note on Tuesday, November 22nd. UBS Group raised their price objective on shares of Agilent Technologies from $152.00 to $170.00 and gave the company a “buy” rating in a research note on Tuesday, December 20th. Wells Fargo & Company raised their price objective on shares of Agilent Technologies from $135.00 to $150.00 in a research note on Tuesday, November 22nd. Finally, KeyCorp raised their price objective on shares of Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Tuesday, November 22nd. Four analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $159.93.
Agilent Technologies Stock Down 2.9 %
Shares of Agilent Technologies stock opened at $147.67 on Monday. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.03 and a quick ratio of 1.47. The company has a 50-day moving average of $148.84 and a 200-day moving average of $135.43. The firm has a market cap of $43.72 billion, a price-to-earnings ratio of 35.41, a PEG ratio of 2.62 and a beta of 1.07. Agilent Technologies has a 1 year low of $112.52 and a 1 year high of $160.26.
Agilent Technologies (NYSE:A – Get Rating) last issued its quarterly earnings data on Monday, November 21st. The medical research company reported $1.53 EPS for the quarter, topping the consensus estimate of $1.39 by $0.14. Agilent Technologies had a net margin of 18.31% and a return on equity of 30.28%. The business had revenue of $1.85 billion during the quarter, compared to analyst estimates of $1.76 billion. During the same period in the prior year, the business earned $1.21 EPS. The company’s revenue for the quarter was up 11.4% on a year-over-year basis.
Agilent Technologies Increases Dividends
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 25th. Investors of record on Tuesday, January 3rd will be issued a $0.225 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. The ex-dividend date is Friday, December 30th. This represents a $0.90 dividend on an annualized basis and a dividend yield of 0.61%. Agilent Technologies’ dividend payout ratio (DPR) is presently 21.58%.
Insider Buying and Selling
In other Agilent Technologies news, VP Padraig Mcdonnell sold 2,746 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, November 22nd. The shares were sold at an average price of $153.21, for a total transaction of $420,714.66. Following the transaction, the vice president now owns 16,201 shares of the company’s stock, valued at $2,482,155.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Agilent Technologies news, SVP Michael Tang sold 3,600 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, November 1st. The shares were sold at an average price of $139.50, for a total transaction of $502,200.00. Following the transaction, the senior vice president now owns 43,280 shares of the company’s stock, valued at $6,037,560. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Padraig Mcdonnell sold 2,746 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, November 22nd. The shares were sold at an average price of $153.21, for a total transaction of $420,714.66. Following the transaction, the vice president now directly owns 16,201 shares in the company, valued at approximately $2,482,155.21. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 222,589 shares of company stock valued at $34,061,140.
Institutional Investors Weigh In On Agilent Technologies
Several institutional investors and hedge funds have recently modified their holdings of the stock. EverSource Wealth Advisors LLC raised its position in shares of Agilent Technologies by 34.8% during the third quarter. EverSource Wealth Advisors LLC now owns 298 shares of the medical research company’s stock valued at $37,000 after buying an additional 77 shares during the last quarter. Baker Avenue Asset Management LP increased its position in Agilent Technologies by 0.3% in the second quarter. Baker Avenue Asset Management LP now owns 28,215 shares of the medical research company’s stock worth $3,351,000 after purchasing an additional 78 shares during the last quarter. King Luther Capital Management Corp increased its position in Agilent Technologies by 0.3% in the third quarter. King Luther Capital Management Corp now owns 24,625 shares of the medical research company’s stock worth $2,993,000 after purchasing an additional 78 shares during the last quarter. CWM LLC increased its position in Agilent Technologies by 1.7% in the second quarter. CWM LLC now owns 4,890 shares of the medical research company’s stock worth $581,000 after purchasing an additional 81 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV increased its position in Agilent Technologies by 1.6% in the second quarter. Massmutual Trust Co. FSB ADV now owns 5,332 shares of the medical research company’s stock worth $633,000 after purchasing an additional 83 shares during the last quarter.
About Agilent Technologies
(Get Rating)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometers; real-time cell analyzers; cell imaging systems; microplate readers; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
Featured Articles
Receive News & Ratings for Agilent Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Agilent Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.
